Press Release - Company Data

China Biologic Completes Transaction to Acquire Additional Equity Stake in Guizhou Taibang
Posted 2014-09-04 00:08NAI Editing
a leading fully integrated plasma-based biopharmaceutical company in China, today announced that it has completed the transaction to acquire an additional 19.84% equity interest in Guizhou Taibang Bio

China Biologic to Increase Equity Stake in Guizhou Taibang
Posted 2014-08-25 00:10NAI Editing
a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its wholly-owned subsidiary Guiyang Dalin Biotechnology Co., Ltd.

China Biologic Announces Pricing of Public Offering of Common Stock
Posted 2014-06-27 00:24NAI Editing
a leading plasma-based biopharmaceutical company in China, today announced the pricing of a follow-on offering of 1,550,000 shares of common stock at a public offering price of $38.00 per share.

China Biologic Announces Favorable Reduction in Value Added Tax Rate
Posted 2014-06-23 00:02NAI Editing
a leading plasma-based biopharmaceutical company in China, today announced that on June 18, 2014, the Ministry of Finance of China and the State Administration of Taxation of China jointly published

China Biologic Announces Receiving GMP Certification at its Guizhou Taibang Facility
Posted 2014-03-18 23:33NAI Editing
a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has received the Good Manufacturing Practice ("GMP") certification from China Food and Dru

China Biologic Completes Stock Repurchase Transaction
Posted 2014-03-02 23:51NAI Editing
a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has completed its repurchase of 2.5 million shares of common stock for a total considerati

China Biologic Waived Application of Preferred Shares Rights Agreement
Posted 2013-06-09 23:39NAI Editing
a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has waived the application of its Preferred Shares Rights Agreement dated as of November 2

China Biologic Updates the Hong Kong Litigation in respect of the Shares Held by Ms. Siu Ling Chan
Posted 2013-06-02 23:32NAI Editing
a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company received a notice (the "Notice") this morning from a Hong Kong solicitors firm representing

China Biologic Comments on the Proposed Shanghai RAAS Transaction
Posted 2013-05-23 23:50NAI Editing
a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has recently learned from a public announcement issued by Shanghai RAAS Blood Products Co.,

China Biologic Reports Financial Results for the First Quarter of 2013
Posted 2013-05-08 10:33NAI Editing
a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the first quarter of 2013.